fda glp-1 compounded warning september 2025 issued 25 letters to telehealth companies for false and misleading claims about products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Beyond the Headlines: FDA Warning

When controlling for a bunch of variables like health and race, the data told an uncomfortable story

CagriSema: This Novo Nordisk combination is a fixed-dose co-formulation of the GLP-1 agonist semaglutide and the long-acting amylin analogue cagrilintide

Like CaMK4 activation, lithium treatment has been reported to reduce synaptic strength in hippocampal neurons [49, 109]

Studies have found that ALCAR has been shown to help support mental function while helping to sharpen learning

BPC-157 helps reduce inflammation associated with chronic injuries, autoimmune conditions, and ongoing physical stressgiving your body a chance to calm down and recover

Sem adoantes artificiais